SSZ

Overview

SSZ is a multi-target inhibitor, which targets multiple pathological mechanisms of Alzheimer's disease (AD). SSZ targets acetylcholinesterase , butyrylcholinesterase , β-site amyloid precursor protein cleavage enzyme 1 ( BACE1 ) , and γ-secretase . SSZ ameliorates Alzheimer’s diseases and exhibits neuroprotective effect in mice.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Cholinesterase (ChE) | Products > Signaling Pathways > Beta-secretase | Products > Signaling Pathways > γ-secretase

Product Information

• Catalog No.: HY-163885
• CAS No.: 1262287-23-9
• Molecular Formula: C18H19ClN4
• Molecular Weight: 326.82
• Purity: 98.13%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source